Wells Fargo analyst Elyse Greenspan lowered the firm’s price target on MetLife (MET) to $93 from $97 and keeps an Overweight rating on the shares. With guidance from most companies in Q4, the firm is generally reducing its EPS estimates as guides were in-line to below consensus expectations for most companies. Wells is also rolling valuation methodologies to 2027 EPS and rolling out new 2028E EPS estimates for companies.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: